These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38106444)

  • 21. Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk.
    Traiber C; Coelho-Amaral P; Ritter VR; Winge A
    J Pediatr (Rio J); 2011 May-Jun 8; 87(3):269-72. PubMed ID: 21461453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.
    Douam F; Ploss A
    Trends Microbiol; 2018 Nov; 26(11):913-928. PubMed ID: 29933925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
    Reis LR; Costa-Rocha IAD; Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Otta DA; Freire LC; Lima SMB; Azevedo AS; Schwarcz WD; Ano Bom APD; Silva AMVD; Souza AF; Castro TDM; Ferroco CLV; Filippis AMB; Nogueira FB; Homma A; Domingues CM; Sousa ESS; Camacho LAB; Maia MLS; Teixeira-Carvalho A; Martins-Filho OA
    Vaccine; 2022 Jan; 40(5):798-810. PubMed ID: 34969545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yellow fever risk assessment in the Central African Republic.
    Staples JE; Diallo M; Janusz KB; Manengu C; Lewis RF; Perea W; Yactayo S; Sall AA;
    Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):608-15. PubMed ID: 24947520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
    Avelino-Silva VI; Miyaji KT; Hunt PW; Huang Y; Simoes M; Lima SB; Freire MS; Caiaffa-Filho HH; Hong MA; Costa DA; Dias JZ; Cerqueira NB; Nishiya AS; Sabino EC; Sartori AM; Kallas EG
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005219. PubMed ID: 27941965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
    Pestana CP; Lawson-Ferreira R; Lessa-Aquino C; Leal MDLF; Freire MDS; Homma A; Medeiros MA
    J Virol Methods; 2018 Oct; 260():82-87. PubMed ID: 30009851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping and Validation of Peptides Differentially Recognized by Antibodies from the Serum of
    Oliveira ES; Tavares NC; Colombarolli SG; Batista ICA; Nascimento CS; Felgner PL; de Assis RR; Calzavara-Silva CE
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
    Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
    Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
    Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren HG
    J Immunol; 2021 Aug; 207(4):1033-1043. PubMed ID: 34321231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.
    James EA; LaFond RE; Gates TJ; Mai DT; Malhotra U; Kwok WW
    J Virol; 2013 Dec; 87(23):12794-804. PubMed ID: 24049183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.
    Burkhard J; Ciurea A; Gabay C; Hasler P; Müller R; Niedrig M; Fehr J; Villiger P; Visser LG; de Visser AW; Walker UA; Hatz C; Bühler S
    Vaccine; 2020 Apr; 38(19):3610-3617. PubMed ID: 31911033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever vaccine protects mice against Zika virus infection.
    Vicente Santos AC; Guedes-da-Silva FH; Dumard CH; Ferreira VNS; da Costa IPS; Machado RA; Barros-Aragão FGQ; Neris RLS; Dos-Santos JS; Assunção-Miranda I; Figueiredo CP; Dias AA; Gomes AMO; de Matos Guedes HL; Oliveira AC; Silva JL
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009907. PubMed ID: 34735450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections.
    Hughes HR; Russell BJ; Mossel EC; Kayiwa J; Lutwama J; Lambert AJ
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29643198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neighbor danger: Yellow fever virus epizootics in urban and urban-rural transition areas of Minas Gerais state, during 2017-2018 yellow fever outbreaks in Brazil.
    Sacchetto L; Silva NIO; Rezende IM; Arruda MS; Costa TA; de Mello ÉM; Oliveira GFG; Alves PA; de Mendonça VE; Stumpp RGAV; Prado AIA; Paglia AP; Perini FA; Lacerda Nogueira M; Kroon EG; de Thoisy B; Trindade GS; Drumond BP
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008658. PubMed ID: 33017419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.
    Nash ER; Brand M; Chalkias S
    J Travel Med; 2015; 22(4):279-81. PubMed ID: 25922988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with yellow fever vaccine failure: A systematic literature review.
    Fantinato FFST; Wachira VK; Porto VBG; Peixoto HM; Duarte EC
    Vaccine; 2023 Mar; 41(13):2155-2169. PubMed ID: 36841725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postpartum varicella vaccination: is the vaccine virus excreted in breast milk?
    Bohlke K; Galil K; Jackson LA; Schmid DS; Starkovich P; Loparev VN; Seward JF
    Obstet Gynecol; 2003 Nov; 102(5 Pt 1):970-7. PubMed ID: 14672472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
    Yang H; Yang H; Li Z; Liu L; Wang W; He T; Fan F; Sun Y; Liu J; Li Y; Zeng X
    Vaccine; 2018 Apr; 36(18):2450-2455. PubMed ID: 29580643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological Protection 5-6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes.
    Idoko OT; Domingo C; Tapia MD; Sow SO; Geldmacher C; Saathoff E; Kampmann B
    Front Immunol; 2020; 11():577751. PubMed ID: 33133096
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.